Yosuke Kunishita Yohei Kirino Naomi Tsuchida Ayaka Maeda Yuichiro Sato Kaoru Takase-Minegishi Ryusuke Yoshimi Hideaki Nakajima
10.3389/fimmu.2022.901063
Front Immunol
2022 Jun 13;13:901063.
1-year follow-up vexas syndrome autoinflammatory diseases relapsing polychondritis tocilizumab (tcz)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35769485/
Polychondritis, Relapsing / complications Polychondritis, Relapsing / diagnosis Polychondritis, Relapsing / drug therapy
Polychondritis, Relapsing / complications Polychondritis, Relapsing / diagnosis Polychondritis, Relapsing / drug therapy Case Reports Observational Study Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized Glucocorticoids Humans Japan Antibodies, Monoclonal, Humanized Glucocorticoids tocilizumab
PMC9234115
35769485
Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan
2022